BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17692261)

  • 1. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
    Orío Hernández M; Yebra Yebra J; Bezanilla López C; Gracia Bouthelier R
    An Pediatr (Barc); 2007 Aug; 67(2):153-6. PubMed ID: 17692261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination growth hormone and gonadotropin releasing hormone analog therapy in 11beta-hydroxylase deficiency.
    Bajpai A; Kabra M; Menon PS
    J Pediatr Endocrinol Metab; 2006 Jun; 19(6):855-7. PubMed ID: 16886593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB; Vogiatzi MG; Harbison MD; New MI
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.
    Lin-Su K; Vogiatzi MG; Marshall I; Harbison MD; Macapagal MC; Betensky B; Tansil S; New MI
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3318-25. PubMed ID: 15797962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of Height after 11 Years of Letrozole Treatment in 11β-Hydroxylase Deficiency.
    Atay Z; Turan S; Buğdaycı O; Guran T; Bereket A
    Horm Res Paediatr; 2019; 92(3):203-208. PubMed ID: 31454824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth Hormone With Aromatase Inhibitor May Improve Height in CYP11B1 Congenital Adrenal Hyperplasia.
    Hawton K; Walton-Betancourth S; Rumsby G; Raine J; Dattani M
    Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28126912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid 11beta- hydroxylase deficiency congenital adrenal hyperplasia.
    Nimkarn S; New MI
    Trends Endocrinol Metab; 2008 Apr; 19(3):96-9. PubMed ID: 18294861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense mutation, GGC(Arg454) --> TGC(Cys), of CYP11B1 gene identified in a Chinese family with steroid 11beta-hydroxylase deficiency.
    Ye ZQ; Zhang MN; Zhang HJ; Jiang JJ; Li XY; Zhang KQ
    Chin Med J (Engl); 2010 May; 123(10):1264-8. PubMed ID: 20529578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medroxyprogesterone acetate. Contributive treatment in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in children].
    La Selve H; Sempé M; Morel Y; Forest MG; de Peretti E; David M
    Arch Fr Pediatr; 1985; 42(7):511-6. PubMed ID: 2935112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M; Bacopoulou I; Savva SC; Skordis N
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency.
    Peter M
    Semin Reprod Med; 2002 Aug; 20(3):249-54. PubMed ID: 12428205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on treatment strategies for optimization of final adult height in children with congenital adrenal hyperplasia.
    Javed A; Lteif A; Kumar S
    Pediatr Endocrinol Rev; 2012 Nov; 10(1):164-73. PubMed ID: 23469393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone and GnRHa combination therapy in the management of precocious puberty.
    Khadilkar VV; Khadilkar VV; Maskati GB
    Indian Pediatr; 2005 Jan; 42(1):57-60. PubMed ID: 15695861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth pattern and final height in 21-hydroxylase deficiency.
    Bajpai A; Pandey RM; Kabra M; Menon PS
    Indian Pediatr; 2007 Oct; 44(10):771-3. PubMed ID: 17998577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prenatal diagnosis and treatment of adrenogenital syndrome. Prevent virilization of female fetuses].
    Lajic S; Bui TH; Holst M; Ritzén M; Wedell A
    Lakartidningen; 1997 Dec; 94(50):4781-6. PubMed ID: 9445959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
    David M; Sempé M; Blanc M; Nicolino M; Forest MG; Morel Y
    Arch Pediatr; 1994 Apr; 1(4):363-7. PubMed ID: 7842090
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.
    Bulsari K; Falhammar H
    Endocrine; 2017 Jan; 55(1):19-36. PubMed ID: 27928728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid responsive hypertension secondary to 11-beta hydroxylase deficiency--a case report.
    Isiavwe AR; Ekpebegh CO; Fasanmade OA; Ohwovoriole AE
    West Afr J Med; 2008 Jul; 27(3):182-5. PubMed ID: 19256327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final height in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the Italian experience.
    Brunelli VL; Russo G; Bertelloni S; Gargantini L; Balducci R; Chiesa L; Livieri C; De Sanctis C; Einaudi S; Virdis R; Saggese G; Chiumello G
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():277-83. PubMed ID: 12729404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with luteinizing hormone releasing hormone agonist (LHRHa) and growth hormone (GH) in central precocious puberty.
    Volta C; Regazzi C; Ndaka J; Vitale R; Bernasconi S
    Acta Biomed; 2005 Sep; 76(2):73-8. PubMed ID: 16350551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.